BioGend Therapeutics Co., Ltd. - Current Ratio

The Current Ratio as of August 2026 (TTM) for BioGend Therapeutics Co., Ltd. (6733.TWO) is 32.13

According to BioGend Therapeutics Co., Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 32.13. This represents a change of 24.96% compared to the average of 25.71 of the last 4 quarters.

BioGend Therapeutics Co., Ltd. (6733.TWO) Historical Current Ratio (quarterly & annually)

How has 6733.TWO Current Ratio performed in the past?

The mean historical Current Ratio of BioGend Therapeutics Co., Ltd. over the last ten years is 22.60. The current 32.13 Current Ratio has changed 14.12% with respect to the historical average. Over the past ten years (40 quarters), 6733.TWO's Current Ratio was at its highest in in the March 2023 quarter at 39.02. The Current Ratio was at its lowest in in the December 2022 quarter at 17.01.

BioGend Therapeutics Co., Ltd. (6733.TWO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of BioGend Therapeutics Co., Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

BioGend Therapeutics Co., Ltd. (6733.TWO) Average Current Ratio

How has 6733.TWO Current Ratio performed in the past?

The current Current Ratio of BioGend Therapeutics Co., Ltd. (6733.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

BioGend Therapeutics Co., Ltd. (6733.TWO) Current Ratio vs. Peers

How is 6733.TWO’s Current Ratio compared to its peers?

BioGend Therapeutics Co., Ltd.’s Current Ratio is greater than Savior Lifetec Corp. (3.96), less than UnicoCell Biomed Co., Ltd. (37.98), greater than Panion & Bf Biotech Inc. (1.28), greater than AnnJi (3.60), less than Formosa Pharmaceuticals, Inc. (0), greater than Medigen Biotechnology Corp. (5.41), greater than TaiGen Biopharmaceuticals Holdings Limited (19.34), greater than Sinphar Pharmaceutical Co. Ltd. (2.37), greater than Pharmosa Biopharm Inc. (18.10), greater than Senhwa Biosciences, Inc. (29.06),

Build a custom stock screener for BioGend Therapeutics Co., Ltd. (6733.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioGend Therapeutics Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioGend Therapeutics Co., Ltd. (6733.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioGend Therapeutics Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.